CNS tumours Flashcards
How are brain tumours classified (WHO)
Grade 1 - Extra-axial:
- Meningothelial cells – meningioma
- Schwann cells – schwannoma
Grade 2-4 Intra-axial (infiltrate the tissue of the brain):
- Astrocytes – astrocytoma
- Oligodendrocytes – oligodendroglioma
- Ependyma – ependymoma
- Neurons – neurocytoma
- Embryonal cells – medulloblastoma (Children)
What are the risk factors for CNS tumours
Largely unknown
Radiation to head and neck → meningiomas, gliomas
Neurocarcinogens
Genetic predisposition (<5%):
- neurofibromatosis (AutDom)
- Tuberous sclerosis
- Brain tumour polyposis syndrome 1
- Gorlin syndrome
- Von Hippel Lindau
What is the inheritance of neurofibromatosis and what CNS tumours does it predispose to
Autosomal dominant
Neurofibromatosis 1 → neurofibroma, astrocytoma
Neurofibromatosis 2→ schwannoma, meningioma
Symptoms and signs of CNS tumours
Headache: worse in the morning/leaning forward/coughing
Persistent or recurrent vomiting
Problems with balance, coordination or walking
Behavioural changes
Abnormal eye movements or changes in vision
Seizures (without fever)
Abnormal head position- wry neck, head tilt or persistent stiff neck
RICP
Papilloedema
Cushing’s triad
Symptoms and signs of CNS tumours according to location
Intracranial: headache, vomiting, changed mental state
Supratentorial: focal neurological deficits, seizures, personality change
Subtentorial: cerebellar ataxia, long tract signs, cranial nerve palsies
Investigations for CNS tumours
MRI head
- MR-spectroscopy (metabolism)
- Perfusion MRI
- functional-MRI
CT head/PET-CT
LP: ?mets in CSF
Management for CNS tumours
MDT
SURGERY
- maximal safe resection to obtain and extensive excision with minimal damage to the patient
- Resectability is dependent on the location, site and number of lesions
- Craniotomy → debulking (subtotal and complete resections)
- Open biopsies → inoperable but approachable tumours
- Stereotactic biopsy → open biopsy not indicated
Radiotherapy and chemotherapy
The use of this varies with tumour type and the age of the patient
Prognosis for CNS tumours
Grade I = benign, long-term survival LOW grade, LONG survival
Grade II = cause death in >5 years LOW grade, LONG survival
Grade III = cause death <5 years HIGH grade, SHORT survival
Grade IV = cause death <1-year HIGH grade, SHORT survival
What is the most common primary CNS tumour
Glial tumours (diffuse or circumscribed)
Circumscribed:
- Pilocytic astroctomas)
- SEGA
- Pleomorphic xanthoastrocytoma
Diffuse
- Diffuse astrocytoma
- Oligodendroma
Describe diffuse glial tumours
High grade, malignant progression
Supratentorial
Adults 20-40yo
IDH1/2 mutation present 30% of cases (+ve prognostic factor)
Astrocytoma (grade 2-4)
Oligodendrogliomas (Grades 2-3)
Describe circumscribed gliomas
Low grade, rarely malignant
Posterior fossa
Seen in children
BRAF mutationpresent in 50% of cases (MAPK pathway mutation)
Pilocytic astrocytoma (grade 1)
Ependymomas (usually)
Subependymal giant cell astrocytoma (Grade 1)
Pleomorphic xanthoastrocytoma (grade II)
Describe pilocytic astrocytomas (epidemiology, associations, imaging appearance, histopathology)
Most common child brain tumour
Seen in NF1 and with BRAF mutatoins
MRI: cerebellar; well circumscribed, cystic, enhancing
Histopathology:
- Piloid (hairy) cell
- Rosenthal fibres and granular bodies
- Slow growing with low mitotic activity
Describe diffuse astrocytomas (epidemiology, associations, imaging appearance)
20-40yo
Cerebral hemispheres (adults), cerebellum (children)
IDH1/2 mutation in 80%
MRI: cerebral hemispheres, non-enhancing lesion, low choline:creatinine ratio
Will eventually become a glioblastoma
Describe glioblastomas (epidemiology, imaging appearance)
> 50yo, most common primary tumour in adults
MRI: solid tumours with central necrosis and a rim that enhances with contrast.
Describe meningiomas (epidemiology, location, imaging appearance, histology)
Second most common primary brain tumour in adults
Largely benign
Arises from the dura mater, seen in the falx cerrebri/superior sagittal sinus
MRI: extra-axial, isodense, contrast-enhancing
Histo: attaches to meninges, does not typically invade (displaces brain matter), globules seen, psammoma bodies